Total hip arthroplasty in HIV-infected patients: A retrospective, controlled study

HIV Medicine

Volumn 13, Issue 10, 2012, Pages 623-629

  Tornero, E ^a   Garcia S ^a   Larrousse, M ^a   Gallart, X ^a   Bori, G ^a   Riba, J ^a   Rios, J ^b   Gatell, J M ^a   Martinez, E ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Femoral necrosis; Hip arthroplasty; HIV

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; FEMUR HEAD NECROSIS; FOLLOW UP; FUNCTIONAL ASSESSMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENGTH OF STAY; LONG TERM SURVIVAL; MALE; OPERATION DURATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL TECHNIQUE; TOTAL HIP PROSTHESIS; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; FEMUR HEAD NECROSIS; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HOSPITALIZATION; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84867520045     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2012.01017.x     Document Type: Article

References (38)

1. Dudkiewicz I, Covo A, Salai M, Israeli A, Amit Y, Chechik A. Total hip arthroplasty alter avascular necrosis of the femoral head: does etiology affect results? Arch Orthop Trauma Surg 2004; 124: 82-85.
2. Goorney BP, Lacey H, Thurairajasingam S, Brown JD. Avascular necrosis of the hip in a man with HIV infection. Genitourin Med 1990; 66: 451-452.
3. Morse CG, Mican JM, Jones EC etal. The incidence and natural history of osteonecrosis in HIV-infected adults. Clin Infect Dis 2007; 44: 739-748.
4. Ries MD, Barcohana B, Davidson A, Jergesen HE, Paiement GD. Association between human immunodeficiency virus and osteonecrosis of the femoral head. J Arthroplasty 2002; 17: 135-139.
5. Allison GT, Bostrom MP, Glesby MJ. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS 2003; 17: 1-9.
6. Lamas JL, Ocampo A, Martínez-Vázquez C etal. Asymptomatic osteonecrosis of the hip in HIV-infected patients. Enferm Infecc Microbiol Clin 2010; 28: 150-155.
7. Yombi JC, Vandercam B, Wilmes D, Dubuc JE, Vincent A, Docquier PL. Osteonecrosis of the femoral head in patients with type 1 human immunodeficiency virus infection: clinical analysis and review. Clin Rheumatol 2009; 28: 815-823.
8. Mary-Krause M, Billaud E, Poizot-Martin I etal. Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy. AIDS 2006; 20: 1627-1635.
9. Molia AC, Strady C, Rouger C, Beguinot IM, Berger JL, Trenque TC. Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy. Ann Pharmacother 2004; 38: 2050-2054.
10. Monier P, McKown K, Bronze MS. Osteonecrosis complicating highly active antiretroviral therapy in patients infected with human immunodeficiency virus. Clin Infect Dis 2000; 31: 1488-1492.
11. Glesby MJ. Bone disorders in human immunodeficiency virus infection. Clin Infect Dis 2003; 37 (Suppl 2): S91-S95.
12. Tsai YC, Liu CH, Liao CH, Chen MY, Hung CC. Osteonecrosis of the femoral head in a human immunodeficiency virus type 1-infected patient with lipodystrophy. J Formos Med Assoc 2002; 101: 210-213.
13. Calza L, Manfredi R, Chiodo F. Osteonecrosis in HIV- infected patients and its correlation with highly active antiretroviral therapy (HAART). Presse Med 2003; 32: 595-598.
14. Bottaro EG, Figueroa RH, Scapellato PG etal. Osteonecrosis in HIV-infected patients. Medicina (B Aires) 2004; 64: 325-331.
15. Ho YC, Shih TT, Lin YH etal. Osteonecrosis in patients with human immunodeficiency virus type 1 infection in Taiwan. Jpn J Infect Dis 2007; 60: 382-386.
16. Mondy K, Tebas P. Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis 2003; 36: S101-S105.
17. Martinez E, Milinkovic A, Buira E etal. Incidence and causes of death in HIV-infected persons receiving highly active antirretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med 2007; 8: 251-258.
18. Hsue PY, Giri K, Erickson S etal. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation 2004; 109: 316-319.
19. Jiménez-Expósito MJ, Mestres CA, Claramonte X etal. Mortality and morbidity in HIV-infected patients undergoing coronary artery bypass surgery: a case control study. Rev Esp Cardiol 2006; 59: 276-279.
20. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 2009 26; 338: a3172.
21. Lehman CR, Ries MD, Paiement GD, Davidson AB. Infection after total joint arthroplasty in patients with human immunodeficiency virus or intravenous drug use. J Arthroplasty 2001; 16: 330-335.
22. Parvizi J, Sullivan TA, Pagnano MW, Trousdale RT, Bolander ME. Total joint arthroplasty in human immunodeficiency virus-positive patients: an alarming rate of early failure. J Arthroplasty 2003; 18: 259-264.
23. Powell DL, Whitener CJ, Dye CE, Ballard JO, Shaffer ML, Eyster ME. Knee and hip arthroplasty infection rates in persons with haemophilia: a 27 year single center experience during the HIV epidemic. Haemophilia 2005; 11: 233-239.
24. National Center for Infections Diseases Division of HIV/AIDS. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41: RR1-R17.
25. Ficat RP. Idiopathic bone necrosis of the femoral head: early diagnosis and treatment. J Bone Joint Surg Br 1985; 67: 3-9.
26. American Society of Anesthesiologists. New classification of physical status [editorial]. Anesthesiology 1963; 24: 111.
27. Merle d'Aubigne R, Postel M. Functional results of hip arthroplasty with acrylic prostheses. J Bone Joint Surg 1945; 36A: 451-475.
28. Mahoney CR, Glesby MJ, DiCarlo EF, Peterson MG, Bostrom MP. Total hip arthroplasty in patients with human immunodeficiency virus infection: pathologic findings and surgical outcomes. Acta Orthop 2005; 76: 198-203.
29. Habermann B, Eberhardt C, Kurth AA. Total joint replacement in HIV positive patients. J Infect 2008; 57: 41-46.
30. Bahebeck J, Eone DH, Nonga BN, Kingue TN, Sosso M. Implant orthopaedic surgery in HIV asymptomatic carriers: management and early outcome. Injury 2009; 40: 1147-1150.
31. Harrison WJ, Lavy CB, Lewis CP. One-year follow-up of orthopaedic implants in HIV-positive patients. Int Orthop 2004; 28: 329-332.
32. Yoo JJ, Chun SH, Kwon YS, Koo KH, Yoon KS, Kim HJ. Operations about hip in human immunodeficiency virus-positive patients. Clin Orthop Surg 2010; 2: 22-27.
33. Harrison WJ. HIV/AIDS in trauma and orthopaedic surgery. J Bone Joint Surg Br 2005; 87: 1178-1181.
34. Wroblewski BM, Siney PD, Fleming PA. Charnley low-frictional torque arthroplasty for avascular necrosis of the femoral. J Arthroplasty 2005; 20: 870-873.
35. Bizot P, Nizard R, Socie G, Gluckman E, Witvoet J, Sedet L. Femoral head osteonecrosis after bone marrow transplantation. Clin Orthop 1998; 357: 127-134.
36. Dudkiewicz I, Covo A, Salai M, Israeli A, Amit Y, Chechik A. Total hip arthroplasty alter avascular necrosis of the femoral head: does etiology affect the results? Arch Orthop Trauma Surg 2004; 24: 82-85.
37. Winkler H. Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft. Int J Med Sci 2009; 6: 247-252.
38. Poggio D, García S, Rovira M, Combalía A, Gallart X, Riba J. Surgical treatment for vascular necrosis of femoral head after hematopoietic stem cell transplantation. Med Clin (Barc) 2006; 127: 738-740.